Sep 26 |
Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday
|
Sep 4 |
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
|
Aug 19 |
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
Aug 12 |
Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman
|
Aug 5 |
IPO Roundup: zSpace, Actuate Therapeutics and more
|
Aug 4 |
Wall Street Breakfast: The Week Ahead
|
Aug 3 |
Investors Prep For High-Stakes Week After Tech Stocks Crumble
|
Jul 2 |
Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes
|
May 30 |
Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1
|